HopeStage
Back to all studies
CompletedNCT02506322

Adjuvant Psychotherapy for Relapse Prevention in Early Adulthood (< 35 yr.) of Bipolarity

Behavioural studyAges 18–55Germany
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
TübingenSee all locations and recruitment
Study clarity

Study information

Study start dateStarted: August 1, 2015
Recruitment status
Completed
Enrollment listed in the registry
318
Sponsor
University Hospital Tuebingen
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention
Study phase
Not clearly listed
Locations
Germany
Age range
From 18 Years to 55 Years
Official registry ID
NCT02506322
Official title
Show the full official title

Adjuvant Psychotherapy for Relapse Prevention in Early Adulthood (< 35 yr.) of Bipolar Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Tübingen

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Hospital Tuebingen, a hospital or academic medical center.

Who was this study for?

Listed age limits: 18 years to 55 years.

Explore other studies

Want to find a study that may fit you better?

Explore HopeStage studies by mental health topic and refine the results to suit your situation.

Find a study that may fit me